Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Sherpa Roméo
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Clés académiques
  • RechercheBible
  • Infrastructure nationale du savoir de Chine (CNKI)
  • Accès à la recherche mondiale en ligne sur l'agriculture (AGORA)
  • Bibliothèque de revues électroniques
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catalogue en ligne SWB
  • Bibliothèque virtuelle de biologie (vifabio)
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

Application of Biotechnology towards Diagnosis and Treatment in Veterinary Medicine in Africa: Potentials and Future Developments

Mohammed BR, Malang SK, Mailafia S and Agbede RIS

Biotechnology is an already established technique in several areas of medicine, but its application in the field of veterinary medicine has only started to emerge with the potential to revolutionize veterinary practice. This paper
therefore reviews the potential applications of biotechnology in veterinary medicine towards diagnosis and treatment in Africa which includes; molecular gene cloning, production of recombinant biotechnology derived vaccines, application of polymerase chain reaction (PCR), Real time polymerase chain reaction (RT-PCR), Polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP) and Bioinformatics to diagnosis of infectious and parasitic diseases , gene therapy, disease diagnosis, treatment delivery systems and many more. These components occur in other parts of the world and are therefore presumed to be consolidated into the African delivery framework as a private enterprise in a foreseeable future. Whilst it is sensible to postulate that biotechnology application and its peculiar evolution will imminently transform veterinary medicine, there is immense treat, amidst stakeholders in the industry, about food health and safety and other civil and ethical concerns which can hinder this novel scientific breakthrough. The ethical concerns which include; theory of the Three Rs (Reduction of animal population, Refinement of enactments and farm managements to curtail affliction and despair, Replacement of animals with non-animal surrogate wherever necessary. Limitations regarding the application to veterinary practices are extensively discussed. This review has implication on the future of revolutionalisation of veterinary practice and increase in animal protein source for human consumption